Regulation of IL-8 gene expression in gliomas by microRNA miR-93

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Fabbri, Enrica ^a   Brognara, Eleonora ^a   Montagner, Giulia ^a   Ghimenton, Claudio ^b   Eccher, Albino ^b   Cantù, Cinzia ^b   Khalil, Susanna ^b   Bezzerri, Valentino ^b   Provezza, Lisa ^b   Bianchi, Nicoletta ^a   Finotti, Alessia ^a   Borgatti, Monica ^a   Moretto, Giuseppe ^b   Chilosi, Marco ^b   Cabrini, Giulio ^b   Gambari, Roberto ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Glioma; IL 8 mRNA; MicroRNA

Indexed keywords

CHEMOKINE; CYTOKINE; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MICRORNA; MICRORNA 93; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; MIRN93 MICRORNA, HUMAN; VASCULOTROPIN A;

3' UNTRANSLATED REGION; ADULT; ANGIOGENESIS; ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GLIOMA; GLIOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; PROTEIN SECRETION; BINDING SITE; BIOLOGICAL MODEL; BRAIN TUMOR; CANCER GRADING; CHEMISTRY; CLUSTER ANALYSIS; CONFORMATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; GENETICS; IN SITU HYBRIDIZATION; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

BASE SEQUENCE; BINDING SITES; BRAIN NEOPLASMS; CELL LINE, TUMOR; CLUSTER ANALYSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; IN SITU HYBRIDIZATION; INTERLEUKIN-8; MICRORNAS; MODELS, BIOLOGICAL; NEOPLASM GRADING; NUCLEIC ACID CONFORMATION; RNA INTERFERENCE; RNA, MESSENGER; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84943522461     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1659-1     Document Type: Article

References (63)

1. Ye F, Gao Q, Cai MJ. Therapeutic targeting of EGFR in malignant gliomas. Expert Opin Ther Targets. 2010;14:303-16.
2. Bhattacharya D, Singh MK, Chaudhuri S, Acharya S, Basu AK, Chaudhuri S. T11TS impedes glioma angiogenesis by inhibiting VEGF signaling and pro-survival PI3K/Akt/eNOS pathway with concomitant upregulation of PTEN in brain endothelial cells. J Neurooncol. 2013;113:13-25.
3. Narayan RS, Fedrigo CA, Stalpers LJ, Baumert BG, Sminia P. Targeting the Akt-pathway to improve radiosensitivity in glioblastoma. Curr Pharm Des. 2013;19:951-7.
4. Nogueira L, Ruiz-Ontañon P, Vazquez-Barquero A, Moris F, Fernandez-Luna JL. The NF?B pathway: a therapeutic target in glioblastoma. Oncotarget. 2011;2:646-53.
5. Qiu B, Zhang D, Wang Y, Ou S, Wang J, Tao J, et al. Interleukin-6 is overexpressed and augments invasiveness of human glioma stem cells in vitro. Clin Exp Metastasis. 2013;30(8):1009-18. Epub Jul 6.
6. Lin Y, Zhang G, Zhang J, Gao G, Li M, Chen Y, et al. A panel of four cytokines predicts the prognosis of patients with malignant gliomas. J Neurooncol. 2013;114:199-208.
7. Yeung YT, McDonald KL, Grewal T, Munoz L. Interleukins in glioblastoma pathophysiology: implications for therapy. Br J Pharmacol. 2013;168:591-606.
8. Zhu VF, Yang J, Lebrun DG, Li M. Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis. Cancer Lett. 2012;316:139-50.
9. Dwyer J, Hebda JK, Le Guelte A, Galan-Moya EM, Smith SS, Azzi S, et al. Glioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2. PLoS One. 2012;7:e45562.
10. Fang KM, Wang YL, Huang MC, Sun SH, Cheng H, Tzeng SF. Expression of macrophage inflammatory protein-1aα and monocyte chemoattractant protein-1 in glioma-infiltrating microglia: involvement of ATP and P2X receptor. J Neurosci Res. 2011;89:199-211.
11. Bonavia R, Inda MM, Vandenberg S, Cheng SY, Nagane M, Hadwiger P, et al. EGFRvIII promotes glioma angiogenesis and growth through the NF-?B, interleukin-8 pathway. Oncogene. 2012;31:4054-66.
12. Raychaudhuri B, Vogelbaum MA. IL-8 is a mediator of NF-?B induced invasion by gliomas. J Neurooncol. 2011;101:227-35.
13. Xie TX, Xia Z, Zhang N, Gong W, Huang S. Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma. Oncol Rep. 2010;23:725-32.
14. Brat DJ, Bellail AC, Van Meir EG. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol. 2005;7:122-33.
15. Neuschäfer-Rube F, Pathe-Neuschäfer-Rube A, Hippenstiel S, Kracht M, Püschel GP. NF-?B-dependent IL-8 induction by prostaglandin E(2) receptors EP(1) and EP(4). Br J Pharmacol. 2013;168:704-17.
16. Finotti A, Borgatti M, Bezzerri V, Nicolis E, Lampronti I, Dechecchi M, et al. Effects of decoy molecules targeting NF-kappaB transcription factors in Cystic fibrosis IB3-1 cells: recruitment of NF-kappaB to the IL-8 gene promoter and transcription of the IL-8 gene. Artif DNA PNA XNA. 2012;3:97-104.
17. Khanjani S, Terzidou V, Johnson MR, Bennett PR. NF?B and AP-1 drive human myometrial IL8 expression. Mediat Inflamm. 2012;504952:8.
18. Bezzerri V, Borgatti M, Finotti A, Tamanini A, Gambari R, Cabrini G. Mapping the transcriptional machinery of the IL-8 gene in human bronchial epithelial cells. J Immunol. 2011;187:6069-81.
19. Wei T, Xu N, Meisgen F, Ståhle M, Sonkoly E, Pivarcsi A. Interleukin-8 is regulated by miR-203 at the posttranscriptional level in primary human keratinocytes. Eur J Dermatol. 2013 Apr 19.
20. Perng DW, Yang DM, Hsiao YH, Lo T, Lee OK, Wu MT, et al. miRNA-146a expression positively regulates tumor necrosis factor-aα-induced interleukin-8 production in mesenchymal stem cells and differentiated lung epithelial-like cells. Tissue Eng Part A. 2012;18:2259-67.
21. Chuang TD, Luo X, Panda H, Chegini N. miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8. Mol Endocrinol. 2012;26:1028-42.
22. Zhou R, Li X, Hu G, Gong AY, Drescher KM, Chen XM. miR-16 targets transcriptional corepressor SMRT and modulates NF-kappaB-regulated transactivation of interleukin-8 gene. PLoS One. 2012;7:e30772.
23. Bhattacharyya S, Balakathiresan NS, Dalgard C, Gutti U, Armistead D, Jozwik C, et al. Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8. J Biol Chem. 2011;286:11604-15.
24. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Orjalo AV, Rodier F, et al. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (Albany NY). 2009;1:402-11.
25. Filipowicz W, Jaskiewicz L, Kolb FA, Pillai FS. Post-transcriptional gene silencing by siRNAs and miRNAs. Curr Opin Struct Biol. 2000;15:331-41.
26. Sontheimer EJ, Carthew RW. Silence from within: endogenous siRNAs and miRNAs. Cell. 2005;122:9-12.
27. Alvarez-Garcia V, Miska EA. MicroRNA functions in animal development and human disease. Development. 2005;132:4653-62.
28. Kailiang S, Lai EC. Adult-specific functions of animal microRNAs. Nat Rev Genet. 2013;14:535-48.
29. Fabbri E, Borgatti M, Montagner G, Bianchi N, Finotti A, Lampronti I, et al. Expression of miR-93 and IL-8 during Pseudomonas aeruginosa mediated Induction of pro-Inflammatory responses. Am J Respir Cell Mol Biol. 2014;50:1144-55.
30. He J, Qian X, Carpenter R, Xu Q, Wang L, Qi Y, et al. Repression of miR-143 mediates Cr (VI)-induced tumor angiogenesis via IGF-IR/IRS1/ERK/IL-8 pathway. Toxicol Sci. 2013;134:26-38.
31. Hu N, Zhang J, Cui W, Kong G, Zhang S, Yue L, et al. miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8. J Biol Chem. 2011;286:13714-22.
32. Keklikoglou I, Koerner C, Schmidt C, Zhang JD, Heckmann D, Shavinskaya A, et al. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-?B and TGF-β signaling pathways. Oncogene. 2012;31:4150-63.
33. Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y, et al. MicroRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci U S A. 2010;107:8231-6.
34. Fang L, Deng Z, Shatseva T, Yang J, Peng C, Du WW, et al. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8. Oncogene. 2011;30:806-21.
35. Long J, Wang Y, Wang W, Chang BH, Danesh FR. Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biol Chem. 2010;285:23457-65.
36. Tarassishin L, Lee SC. Interferon regulatory factor 3 alters glioma inflammatory and invasive properties. J Neurooncol. 2013;113:185-94.
37. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97-109.
38. Cao X, Gu Y, Jiang L, Wang Y, Fang L, Yuqiao X, et al. A new approach to screening cancer stem cells from the U251 human glioma cell line based on cell growth state. Oncol Rep. 2013;29:1013-8.
39. Stein GH. T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro. J Cell Physiol. 1979;99:43-54.
40. Borgatti M, Mancini I, Bianchi N, Guerrini A, Lampronti I, Rossi D, et al. Bergamot (Citrus bergamia Risso) fruit extracts and identified components alter expression of interleukin 8 gene in cystic fibrosis bronchial epithelial cell lines. BMC Biochem. 2011;15:12-5.
41. Penolazzi L, Lambertini E, Tavanti E, Torreggiani E, Vesce F, Gambari R, et al. Evaluation of chemokine and cytokine profiles in osteoblast progenitors from umbilical cord blood stem cells by Bio-Plex technology. Cell Biol Int. 2008;32:320-5.
42. Fabbri E, Manicardi A, Tedeschi T, Sforza S, Bianchi N, Brognara E, et al. Modulation of the Biological Activity of microRNA-210 with Peptide Nucleic Acids (PNAs). ChemMedChem. 2011;12:2192-202.
43. Gambari R, Fabbri E, Borgatti M, Lampronti I, Finotti A, Brognara E, et al. Targeting microRNAs involved in human diseases: A novel approach for modification of gene expression and drug development. Biochem Pharmacol. 2011;82:1416-29.
44. Yu Y, Feng J, Zong X, Yang H, Zou D, He X. Knockdown of vascular endothelial cell growth factor expression sensitizes U251 glioma cells to liposomal paclitaxel and radiation treatment in vitro. Exp Ther Med. 2012;3:181-6.
45. Takahashi H, Inoue A, Kawabe Y, Hosokawa Y, Iwata S, Sugimoto K, et al. Oct-3/4 promotes tumor angiogenesis through VEGF production in glioblastoma. Brain Tumor Pathol. 2015;32:31-40.
46. Braganhol E, Kukulski F, Lévesque SA, Fausther M, Lavoie EG, Zanotto-Filho A, et al. Nucleotide receptors control IL-8/CXCL8 and MCP-1/CCL2 secretions as well as proliferation in human glioma cells. Biochim Biophys Acta. 2015;1852:120-30.
47. Nijaguna MB, Patil V, Hegde AS, Chandramouli BA, Arivazhagan A, Santosh V, et al. An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals. PLoS ONE. 2015;10(9).
48. Vartanian A, Singh SK, Agnihotri S, Jalali S, Burrell K, Aldape KD, et al. GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity. Neuro Oncol. 2014;16:1167-75.
49. Singh SK, Vartanian A, Burrell K, Zadeh G. A microRNA Link to Glioblastoma Heterogeneity. Cancers. 2012;4:846-72.
50. Petrocca F, Vecchione A, Croce CM. Emerging role of miR-106b-25/miR-17-92clusters in the control of transforming growth factor beta signaling. Cancer Res. 2008;68:8191-4.
51. Codo P, Weller M, Meister G, Szabo E, Steinle A, Wolter M, Reifenberger G, Roth P. MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape. Oncotargets. 2014. Online ISSN: 1949-2553
52. Sun S, Wang Q, Giang A, Cheng C, Soo C, Wang CY, et al. Knockdown of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-?B. J Neurooncol. 2011;101:1-14.
53. Gabellini C, Castellini L, Trisciuoglio D, Kracht M, Zupi G, Del Bufalo D. Involvement of nuclear factor-kappa B in bcl-xL-induced interleukin 8 expression in glioblastoma. J Neurochem. 2008;107:871-82.
54. Yang TQ, Lu XJ, Wu TF, Ding DD, Zhao ZH, Chen GL, et al. MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-?B1/MMP9 signaling pathway. Cancer Sci. 2014;105:265-71.
55. Liu S, Patel SH, Ginestier C, Ibarra I, Martin-Trevino R, Bai S, et al. MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells. PLoS Genet. 2012;8:e1002751.
56. Yang G, Han D, Chen X, Zhang D, Wang L, Shi C, et al. MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of I?Baα both in vitro and in vivo. Neuro Oncol. 2014;16:652-61.
57. Magge SN, Malik SZ, Royo NC, Chen HI, Yu L, Snyder EY, et al. Role of monocyte chemoattractant protein-1 (MCP-1/CCL2) in migration of neural progenitor cells toward glial tumors. J Neurosci Res. 2009;87:1547-55.
58. Nazarenko I, Hede SM, He X, Hedrén A, Thompson J, Lindström MS, et al. PDGF and PDGF receptors in glioma. Ups J Med Sci. 2012;117:99-112.
59. Pyonteck SM, Akkari L, Schuhmacher AJ, Bowman RL, Sevenich L, Quail DF, et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med. 2013;19:1264-72.
60. van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry. 1998;31:1-9.
61. McIlwain DR, Berger T, Mak TW. Caspase Functions in Cell Death and Disease. Cold Spring Harb Perspect Biol. 2013;5:a008656.
62. Brognara E, Fabbri E, Bazzoli E, Montagner G, Ghimenton C, Eccher A, et al. Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221. J Neurooncol. 2014;118:19-28.
63. Aboud OA, Wettersten HI, Weiss RH. Inhibition of PPARaα Induces Cell Cycle Arrest and Apoptosis, and Synergizes with Glycolysis Inhibition in Kidney Cancer Cells. Plos One. 2013;8(8):e71115.